FABP1 and diabetic kidney disease: The recent study highlights that while elevated levels of urinary NGAL and L-FABP are observed in DKD patients, these biomarkers are also increased in various non-diabetic CKD conditions, such as hypertensive nephrosclerosis and glomerulonephritis.